259 related articles for article (PubMed ID: 9657124)
21. Hepatocellular carcinoma (primary cancer of the liver).
Barbare JC; Boige V; Boudjema K; Lescesne R; Trinchet JC
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S57-2S61. PubMed ID: 17151564
[No Abstract] [Full Text] [Related]
22. Hepatocellular carcinoma: from ethanol injection to liver transplantation.
Bismuth H; Majno P; Adam R
Acta Gastroenterol Belg; 1999; 62(3):330-41. PubMed ID: 10547900
[No Abstract] [Full Text] [Related]
23. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
Bhattacharya S; Dusheiko GM
Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
[TBL] [Abstract][Full Text] [Related]
24. [Chemoembolization techniques for hepatocellular carcinoma in cirrhosis].
Vetter D; Bronowicki JP; Doffoël M
Ann Chir; 1998; 52(6):527-34. PubMed ID: 9752502
[TBL] [Abstract][Full Text] [Related]
25. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
26. Treatment of unresectable hepatocellular carcinoma.
Bismuth H; Samuel D; Engerran L
N Engl J Med; 1995 Sep; 333(13):878. PubMed ID: 7544440
[No Abstract] [Full Text] [Related]
27. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma (Br J Surg 2003; 90: 325-331).
Sen G; Rai R; Manas DM
Br J Surg; 2003 Aug; 90(8):1022. PubMed ID: 12905563
[No Abstract] [Full Text] [Related]
28. Preoperative chemoembolization for hepatocellular carcinoma.
Morino M; Miglietta C; Grosso M; De Giuli M; Bismuth H
J Surg Oncol Suppl; 1993; 3():91-3. PubMed ID: 8389180
[TBL] [Abstract][Full Text] [Related]
29. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hepatocellular carcinoma.
Nicoli N; Marchiori L; Mansueto GC; Morana G; Bellini A; Musajo F; Bortolasi L; Dal Dosso I; Costa V; Pederzoli P
J Surg Oncol Suppl; 1993; 3():70-3. PubMed ID: 8389176
[No Abstract] [Full Text] [Related]
31. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
[TBL] [Abstract][Full Text] [Related]
32. Delayed cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Wu JJ; Chao M; Zhang GQ; Li B
Chin Med J (Engl); 2009 Apr; 122(7):878-80. PubMed ID: 19493407
[No Abstract] [Full Text] [Related]
33. Downstaging hepatocellular carcinoma prior to liver transplantation.
Gamblin TC; Geller DA
Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
[No Abstract] [Full Text] [Related]
34. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
35. Preoperative TNM staging of hepatocellular carcinoma in hepatic transplantation: value of lipiodol computed tomography.
Valls C; Figueras J; Pamies JJ; Virgili J; Sancho C; Dominguez J; Montaña X; Benasco C; Casais L; Jaurrieta E
Transplant Proc; 1995 Aug; 27(4):2309-10. PubMed ID: 7652821
[No Abstract] [Full Text] [Related]
36. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
38. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
[TBL] [Abstract][Full Text] [Related]
39. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
40. [The preoperative chemoembolization of hepatocarcinoma due to cirrhosis].
Savastano S; Feltrin GP; Miotto D; Chiesura-Corona M; Casarrubea G; Cecchetto A
Radiol Med; 1994 Nov; 88(5):620-4. PubMed ID: 7824778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
